DOCUMENT YOUR TREATMENT IMPACT
The launch of your new medical product doesn’t mark an end to your work – it’s just the beginning.
It’s important to document the impact of your medical treatment in the post-marketing phase. This data is available and often requested by patients, health care practitioners (HPC) and payers.
Why? Because your stakeholders want evidence of what works in the real world. DLIMI consultants can help you use relevant data and appropriate methodologies to see the impact and plan your next step.
Working with real-world evidence is a challenge. Organisations must work as a team and overcome the traditional barrier between medical and market access. But exploring treatment impact can also be an opportunity to sharpen your focus and target new audiences who can benefit from your product. It will also help you meet the expectations of public authorities.
“We analyse the dynamics behind the market, which leads to insights based on the patient treatment reality – insights that are valuable not only to you, but to patients, HCPs and payers.”
Mads Obi Bergsten
REAL WORLD EVIDENCE WORKSHOP
yOUR JOURNEY TOWARDS rEAL-wORLD EXCELLENCE
Working with real-world evidence tends to bring people together. It brings you closer to your market and an understanding of the impact your treatment has in real life situations.
real world risk/benefit
provide the knowledge authorities request
Real-world can involve professionals across the organisation and introduce new ways of working. They also take up a lot of resources. Plan your studies wisely to see your efforts pay off.
New collaboration with Medaffcon
Enhancing Nordic RWE studies
The combined expertise of DLIMI and Medaffcon represent the fields of RWE, medical and data sciences, and health economics and with this collaboration we can conduct even better real world studies in order to strengthen patient centric access to medicine.